71 related articles for article (PubMed ID: 21960365)
21. Genetic and epigenetic predictors of responsiveness to treatment in RA.
Plant D; Wilson AG; Barton A
Nat Rev Rheumatol; 2014 Jun; 10(6):329-37. PubMed ID: 24535543
[TBL] [Abstract][Full Text] [Related]
22. Beyond E-cadherin: roles of other cadherin superfamily members in cancer.
van Roy F
Nat Rev Cancer; 2014 Feb; 14(2):121-34. PubMed ID: 24442140
[TBL] [Abstract][Full Text] [Related]
23. Tumour suppressor genes in chemotherapeutic drug response.
Lai D; Visser-Grieve S; Yang X
Biosci Rep; 2012 Aug; 32(4):361-74. PubMed ID: 22762204
[TBL] [Abstract][Full Text] [Related]
24. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogene regulatory elements: from discovery to applications.
Smith RP; Lam ET; Markova S; Yee SW; Ahituv N
Genome Med; 2012 May; 4(5):45. PubMed ID: 22630332
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation analysis of bone marrow cells at diagnosis of acute lymphoblastic leukemia and at remission.
Nordlund J; Milani L; Lundmark A; Lönnerholm G; Syvänen AC
PLoS One; 2012; 7(4):e34513. PubMed ID: 22493696
[TBL] [Abstract][Full Text] [Related]
27. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
[TBL] [Abstract][Full Text] [Related]
28. PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis.
Narayan G; Xie D; Freddy AJ; Ishdorj G; Do C; Satwani P; Liyanage H; Clark L; Kisselev S; Nandula SV; Scotto L; Alobeid B; Savage D; Tycko B; O'Connor OA; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2013 Nov; 52(11):1030-41. PubMed ID: 23929756
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inactivation of PCDH10 in human prostate cancer cell lines.
Li Z; Li W; Xie J; Wang Y; Tang A; Li X; Ye J; Gui Y; Cai Z
Cell Biol Int; 2011 Jul; 35(7):671-6. PubMed ID: 21314642
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
32. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
[TBL] [Abstract][Full Text] [Related]
33. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation and miRNA expression profiling in childhood B-cell acute lymphoblastic leukemia.
Chatterton Z; Morenos L; Saffery R; Craig JM; Ashley D; Wong NC
Epigenomics; 2010 Oct; 2(5):697-708. PubMed ID: 22122053
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
